Human plasminogen is highly susceptible to peroxynitrite inactivation

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 8, 2003, Pages 1064-1068

  Gugliucci, Alejandro ^a  

^a Touro University California   (United States)

Author keywords

Diabetes; Nitrosative stress; Peroxynitrite; Plasminogen

Indexed keywords

ANTIOXIDANT; ANTITHROMBIN III; CARBONYL DERIVATIVE; FRUCTOSE; GLUCOSE; LINSIDOMINE; PEROXYNITRITE; PLASMA PROTEIN; PLASMINOGEN; STREPTOKINASE; TYROSINE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; GLYCATION; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; INCUBATION TIME; NITRATION; OXIDATION; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; STRESS; THROMBOGENESIS; THROMBOGENICITY; THROMBOSIS; TIME;

ANTITHROMBIN III; CHROMOGENIC COMPOUNDS; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS; DRUG COMBINATIONS; ENZYME INHIBITORS; FRUCTOSE; GLUCOSE; HUMANS; MOLSIDOMINE; NITRATES; OXIDANTS; PLASMA; PLASMINOGEN; STREPTOKINASE;

EID: 0041853063     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.164     Document Type: Article

References (28)

1. Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 2001; 15:44-54.
2. Acang N, Jalil FD. Hypercoagulation in diabetes mellitus. Southeast Asian J Trop Med Public Health 1993; 24:263-6.
3. Gugliucci A, Ghitescu L. Is diabetic hypercoagulability an acquired annexinopathy? Glycation of annexin II as a putative mechanism for impaired fibrinolysis in diabetic patients. Med Hypotheses 2002; 59:247-51.
4. Gugliucci A. Glycation as the glucose link to diabetic complications. J Am Osteopath Assoc 2000; 100:621-34.
5. Schmidt AM, Stern D. Atherosclerosis and diabetes: the RAGE connection. Curr Atheroscler Rep 2000; 2:430-6.
6. Vlassara H. Intervening in atherogenesis: lessons from diabetes. Hosp Pract (Off Ed) 2000; 35:25-7, 32, 35-9.
7. Hausladen A, Stamler JS. Nitrosative stress. Methods Enzymol 1999; 300:389-95.
8. Nagai R, Unno Y, Hayashi MC, Masuda S, Hayase F, Kinae N, et al. Peroxynitrite induces formation of N(epsilon)-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite. Diabetes 2002; 51:2833-9.
9. Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Riggs JE, Warehime SS, et al. Nitrosative stress, uric acid, and peripheral nerve function in early type 1 diabetes. Diabetes 2002; 51:2817-25.
10. Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 1998; 14:241-9.
11. Inoue H, Hisamatsu K, Ando K, Ajisaka R, Kumagai N. Determination of nitrotyrosine and related compounds in biological specimens by competitive enzyme immunoassay. Nitric Oxide 2002; 7:11-7.
12. Khan J, Brennand DM, Bradley N, Gao B, Bruckdorfer R, Jacobs M, et al. 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem J 1998; 330(Pt 2):795-801.
13. Kikugawa K, Nakauchi K, Beppu M, Hiramoto K, Ando K, Hayakawa M. Is nitrotyrosine generated in human erythrocytes in circulation? Biol Pharm Bull 2000; 23:379-85.
14. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 2002; 61:186-94.
15. Gugliucci A, Menini T. The botanical extracts of Achyrocline satureoides and Ilex paraguariensis prevent methylglyoxal-induced inhibition of plasminogen and antithrombin III. Life Sci 2002; 72:279-92.
16. Soria J, Soria C, Samama M. [Plasminogen determination, using a chromogenic tripeptidic substrate (authors' translation)]. Pathol Biol (Paris) 1976; 24:725-9.
17. Frantzen Handeland G, Abildgaard U, Aasen AO. Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated method. Scand J Haematol 1983; 31:427-36.
18. Cantoni O, Palomba L, Guidarelli A, Tommasini I, Cerioni L, Sestili P. Cell signaling and cytotoxicity by peroxynitrite. Environ Health Perspect 2002; 110:823-5.
19. Minetti M, Mallozzi C, Di Stasi AM, Pietraforte D. Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch Biochem Biophys 1998; 352:165-74.
20. Skinner KA, White CR, Patel R, Tan S, Barnes S, Kirk M, et al. Nitrosation of uric acid by peroxynitrite. Formation of a vasoactive nitric oxide donor. J Biol Chem 1998; 273: 24491-7.
21. Coert BA, Anderson RE, Meyer FB. Effects of the nitric oxide donor 3-morpholinosydnonimine (SIN-1) in focal cerebral ischemia dependent on intracellular brain pH. J Neurosurg 2002; 97:914-21.
22. Lelamali K, Wang W, Gengaro P, Edelstein C, Schrier RW. Effects of nitric oxide and peroxynitrite on endotoxin-induced leukocyte adhesion to endothelium. J Cell Physiol 2001; 188:337-42.
23. Lupidi G, Angeletti M, Eleuteri AM, Tacconi L, Coletta M, Fioretti E. Peroxynitrite-mediated oxidation of fibrinogen inhibits clot formation. FEBS Lett 1999; 462:236-40.
24. Serra PA, Rocchitta G, Esposito G, Delogu MR, Migheli R, Miele E, et al. A study on the role of nitric oxide and iron in 3-morpholino-sydnonimine-induced increases in dopamine release in the striatum of freely moving rats. Br J Pharmacol 2001; 134:275-82.
25. Gugliucci A, Menini T. Three different pathways for human LDL oxidation are inhibited in vitro by water extracts of the medicinal herb Achyrocline satureoides. Life Sci 2002; 71:693-705.
26. Castellino FJ, McCance SG. The kringle domains of human plasminogen. Ciba Found Symp 1997; 212:46-60.
27. Dobrovolsky AB, Titaeva EV. The fibrinolysis system: regulation of activity and physiologic functions of its main components. Biochemistry (Mosc) 2002; 67:99-108.
28. Pignatelli B, Li CQ, Boffetta P, Chen Q, Ahrens W, Nyberg F, et al. Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res 2001; 61:778-84.